首页> 外文会议>International Conference on Bioinformatics and Biomedical Engineering >Molecular Docking and Biological Evaluation of Functionalized benzohquinolines as Colon Cancer Agents
【24h】

Molecular Docking and Biological Evaluation of Functionalized benzohquinolines as Colon Cancer Agents

机译:功能化的苯并h喹啉作为结肠癌药物的分子对接和生物学评价

获取原文

摘要

As a part of our drug discovery program, we have synthesized various 2-amino-benzo[h]quinoline-6-carbonitrile derivatives and analyzed them on human colon cancer cells in the form of percentage inhibition at different concentration gradient and time of incubation. Anticancer activity of these derivatives against the human HCT116 cancer cells using in vitro employing standard MTT assay. Compounds 3a-3e showed significant anti-cancer activity especially compound 3b and 3d exhibit the good inhibitory activity on HCT116 cells. Additionally, docking study was performed on colon cancer target cyclin-dependent kinase-2 to understand the cytotoxic mechanism of action of active compounds.
机译:作为药物发现计划的一部分,我们合成了各种2-氨基-苯并[h]喹啉-6-腈衍生物,并在不同浓度梯度和孵育时间下以百分比抑制的形式在人结肠癌细胞上进行了分析。这些衍生物在体外采用标准MTT测定法对人HCT116癌细胞的抗癌活性。化合物3a-3e显示出显着的抗癌活性,尤其是化合物3b和3d显示出对HCT116细胞的良好抑制活性。此外,对结肠癌靶细胞周期蛋白依赖性激酶2进行了对接研究,以了解活性化合物作用的细胞毒性机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号